SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
72Sorry. Must have chopped reference off inadvertently... nignigel bates-10/9/2000
71Re. intrinsic capacity of Abs by Wentworth et al. This was published in the 9/2Pseudo Biologist-10/9/2000
70Nigel, this is interesting. Where was it published? Jasontnsaf-10/9/2000
69Antibodies have the intrinsic capacity to destroy antigens Anita D. Wentworth,nigel bates-10/5/2000
68Decent overview of ab therapies etc in NYT science section today. <eom>scott_jiminez-10/3/2000
67Oct. 2 /PRNewswire/ -- Abgenix, Inc. (Nasdaq: ABGX - news) today announced the fnigel bates-10/2/2000
66<i>Sept. 28 /PRNewswire/ -- Eos Biotechnology, Inc. today announced the conigel bates-9/28/2000
65Sept. 26 /PRNewswire/ -- Abgenix, Inc. (Nasdaq: ABGX - news) and ImmGenics, Inc.nigel bates-9/27/2000
64Sept. 25 /PRNewswire/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN - news) todnigel bates-9/25/2000
63ftmarketwatch.com{46B5826C-F90B-441D-B04C-0F1EED50D550} "LONDON (FTMW) -- Snigel bates-9/25/2000
62GENMAB A/S ANNOUNCES IPO PRICE RANGE AND PUBLICATION OF OFFERING CIRCULAR This nigel bates-9/25/2000
61Sep 20 (Reuters Health) - Scientists from the University of Illinois have develonigel bates-9/24/2000
60Relevant ? Message 14407794 Sept. 19, 2000--Targeted Genetics Corporation (Nasdanigel bates-9/19/2000
59Sept. 18 /PRNewswire/ -- Protein Design Labs, Inc. (PDL) (Nasdaq: PDLI - news) tnigel bates-9/18/2000
58Message 14403657nigel bates-9/18/2000
57Another interesting angle on protein pharmaceuticals - Message 14389286 nignigel bates-9/15/2000
56Of all the articles previously referred to here in the August Immunology Today, keokalani'nui-9/14/2000
55>> even down to the collaboration with OGS. << not to mention Eos..scaram(o)uche-9/11/2000
54From the Genmab announcement - "Genmab has corporate collaborations with Menigel bates-9/11/2000
53CEO delivering the goods. In conference call last month, he indicated a series oLarry Liebman-9/11/2000
52Deal flow from MEDX has been remarkable recently.... nignigel bates-9/11/2000
51Message 14360298 LONDON, Sept 11 (Reuters) - British biotech company Oxford Glycnigel bates-9/11/2000
50PR Newswire, London, September 11. This press release is transmitted on behalf onigel bates-9/11/2000
49PDLI still in the game ..... Sept. 7 /PRNewswire/ -- Protein Design Labs, Inc. nigel bates-9/7/2000
48I must confess to a small speculative holding in IMGN, fairly recently acquired.nigel bates-9/6/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News